Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups

Digestive Diseases and Sciences

Volumn 41, Issue 12 SUPPL., 1996, Pages

  Tillmann, Hans L ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

epidemiology; hepatitis C virus; posttransfusion hepatitis; risk factors

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; HEPATITIS C; HIGH RISK POPULATION; HUMAN; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; VIRUS TRANSMISSION;

EID: 0030455290     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02087874     Document Type: Conference Paper

References (221)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362, 1989
2. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Berger K, Shuster JR, Overby LR, Bradly W, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B viral hepatitis genome. Science 244:362-364, 1989
3. Van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo Q-L, Kuo G, Houghton M: Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 2:297-298, 1989
4. Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, Vargas V, Genscá J, Briti M, Guardia J, Houghton M, Choo Q-L, Kuo G: Hepatitis C virus antibodies among risk groups in Spain. Lancet 2:294-297, 1989
5. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500, 1989
6. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo Q-L, Kuo G: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 87:983-987, 1990
7. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW: Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46:423-441, 1990
8. Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107-1112, 1990
9. Aach RD, Stevens CE, Hollinger B, Mosely JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ: Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325:1325-1329, 1991
10. Feinman SV, Berris B, Herst R: Anti-HCV in post-transfusion hepatitis: Deductions from a prospective study. J Hepatol 12:377-381, 1991
11. Bortolotti F, Tagger A, Cadrobbi P, Crivellaro C, Pregliasco F, Ribero ML, Alberti A: Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. J Hepatol 12:176-180, 1991
12. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ for the Sentinal Counties Chronic Non-A, Non-B Hepatitis Study Team: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905, 1992
13. Fagan EA, Harrison TJ: Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis. J Hepatol 21:587-591, 1994
14. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S, McMaster P, Elias E: Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A, non-B hepatitis. Gut 36:433-436, 1995
15. Brillanti S, Masci C, Ricci P, Miglioli M, Barbara L: Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. Hepatology 15:998-1001, 1992
16. Douglas DD, Rakela J, Taswell HF, Persin DH, Wilber J, Sanchez-Pescador R, Neuwald P, Urdea MS: Correlation of quantitative HCV RNA, anti-HCV IgM, and serum ALT with histologic presentation. Hepatology 16:201A, 1992 (abstract)
17. Jeffers LJ, Hasan F, De Medina M, Reddy R, Parker T, Silva M, Mendez L, Schiff ER, Manns M, Houghton M, Choo Q-L, Kuo G: Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 15:187-190, 1992
18. Brown J, Dourakis S, Karayiannis P, Goldin R, Chiba J, Ohba H, Miyamura T, Thomas HC: Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease. Hepatology 15:175-179, 1992
19. Bortolotti F, Vajro P, Cadrobbi P, Lepore L, Zancan L, Barbera C, Crivellaro C, Fontanella A, Alberti A, D'Addezio M: Cryptogenic chronic liver disease and hepatitis C virus infection in children. J Hepatol 15:73-76, 1992
20. Brind AM, Codd AA, Cohen BJ, Gabriel FG, Collins JD, James OFW, Bassendine MF: Low prevalence of antibody to hepatitis C virus in north east England. J Med Virol 32:243-248, 1990
21. Mansell CJ, Locarnini SA: Epidemiology of hepatitis C in the East. Semin Liver Dis 15:15-32, 1995
22. Prohaska W, Wolff C, Lechler E, Kleesiek K: High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate? Klin Wochenschr 69:294-296, 1991
23. Widell A, Månsson A-S, Sundström G, Hansson BG, Nordenfelt E: Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 35:253-258, 1991
24. Boxall E, Skidmore S, Evans C, Nightingale S: The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect 113:523-528, 1994
25. Larsen J, Hetland G, Skaug K, Maeland A: Viral hepatitis and blood transfusion. Tidsskr Nor Laegeforen 111:825-828, 1991 (in Norwegian)
26. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D'Amico E, Cambiè G, Vecchi L, and the Lombardi Study Group on Vertical HCV Transmission: Mother-to-infant transmission of hepatitis C virus. Lancet 345:289-291, 1995
27. Marcellin P, Bernuau J, Martinot-Peignoux M, Larzul D, Xu L-Z, Tran S, Bezeaud A, Guimont M-C, Levardon M, Aumont P, Erlinger S, Benhamou J-P: Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children. Dig Dis Sci 38:2151-2155, 1993
28. Roudot-Thoraval F, Pawlotsky J-M, Thiers V, Deforges L, Girollet P-P, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D: Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing. Hepatology 17:772-777, 1993
29. Trautwein C, Kiral G, Tilimann HL, Witteler H, Michel G, Manns MP: Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union. J Med Virol 45:429-434, 1995
30. Lystar' BN, Skvortsov SV, Poliakova II, Lovanova VIu, Belov EV: Detection of antibodies to hepatitis C virus in blood donors. Gematol Transfuziol 38:29-31, 1993 (in Russian)
31. Ndumbe PM, Skalsky J, Joller-Jemelka HI: Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon. APMIS 102:662-666, 1994
32. Saleh MG, Pereira LMMB, Tibs CJ, Ziu M, Al-Fituri MO, Williams R, McFarlane IG: High prevalence of hepatitis C virus in normal Libyan population. Trans R Soc Trop Med Hyg 88:292-294, 1994
33. Darwish M, Faris R, Clemens J, Rao M, Edelman R: Hepatitis C virus. Lancet 345:190-191, 1995 (letter)
34. Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C: Epidemiology of hepatitis C virus: A study of male blood donors in Saudi Arabia. Transfusion 34:135-137, 1994
35. Deseda CC, Sweeney PA, Woodruff BA, Lindegren ML, Shapiro CN, Onorato IM: Prevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infection among women attending prenatal clinics in San Juan, Puerto Rico, from 1989-1990. Obstet Gynecol 85:75-78, 1995
36. Nkengasong JN, De Beenhouwer H, Claeys H, Nyambi P, Ayuk J, van der Groen G, Ndumbe P: A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. Am J Trop Med Hyg 52:98-100, 1995
37. Soni PN, Tait DR, Kenoyer DG, Fernandes-Costa F, Naicker S, Gopaul W, Simjee AE: Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 40:65-68, 1993
38. Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ: Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 21:196-200, 1993
39. Irving WL, Neal KR, Underwood JCE, Simmonds PN, James V, on behalf of Trent Regional Hepatitis C Virus Study Group: Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Br Med J 308:695-696, 1994
40. Nordøy I, Schrumpf E, Elgjo K, Flesland Ø, Andersen Glende J, Ørjasæter U, Siebke J-C: Liver disease in anti-hepatitis C virus positive Norwegian blood donors. Scand J Gastroenterol 29:77-81, 1994
41. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A: Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340:697-698, 1992
42. Kuboki M, Shinzawa H, Ishibashi M, Yoshii E, Takahashi T, Iinuma K: Hepatitis C virus infection and liver disease in ALT normal individuals with anti-HCV positive. Gastroenterology 104(suppl):A931, 1993 (abstract)
43. Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L: Persistent hepatitis C viraemia without liver disease. Lancet 341:464-465, 1993
44. Inoue Y, Takeuchi K, Chou W-H, Unayama T, Takahashi K, Saito I, Miyamura T: Silent mother-to-child transmission of hepatitis C virus through two generations determined by comparative nucleotide sequence analysis of the viral cDNA. J Infect Dis 166:1425-1428, 1992
45. Yuki N, Hayashi N, Takehara T, Hagiwara H, Hiramatsu N, Naito M, Kawanishi Y, Katayama K, Kasahara A, Fusamoto H, Kamada T: Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol 89:1462-1466, 1994
46. Mathiesen UL, Ekermo B, Foberg U, Franzén L, Frydén A, Norlin R, Pettersson L-G, Sterling H, Widell A, Bodemar G: Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas. Scand J Gastroenterol 27:443-448, 1992
47. Watanabe M, Ohkoshi S, Tawaraya H, Miyajima T, Shimotohno K, Kamimura T, Asakura H: Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission. Transfusion 34:125-129, 1994
48. Mattsson L, Grillner L, von Sydow M, Bergdahl S, Weiland O: Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Infection 19:309-312, 1992
49. Wang J-T, Wang T-H, Lin J-T, Sheu J-C, Sung J-L, Chen D-S: Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan. J Med Virol 32:83-86, 1990
50. Nishioka K, Watanabe J, Furuta S, Tanaka E, Suzuki H, Iino S, Tsuji T, Yano M, Kuo G, Choo Q-L, Houghton M, Oda T: Antibody to the hepatitis C virus in acute hepatitis and chronic liver disease in Japan. Liver 11:65-70, 1991
51. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 114:277-281, 1991
52. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LCM, Cuypers HTM, Lelis PN, van Oers MHJ: Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 345:95-96, 1995
53. Ni Y-H, Chang M-H, Lue H-C, Hsu H-Y, Wang M-J, Chen P-J, Chen D-S: Posttransfusion hepatitis C virus infection in children. J Pediatr 124:709-713, 1994
54. Bortolloti F, Jara P, Diaz C, Vajro P, Hierro L, Giachino R, de la Vega A, Crivellaro C, Camarena C, Barbera C, Mebbia G, Zancan L, de Moliner L: Post transfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 18:279-283, 1994
55. Lelie PN, Cuypers HT, Reesink HW, van der Poel CL, Winkel I, Bakker E, van Exel-Oehlers PJ, Vallari D, Allain JP, Mimms L: Patterns of serological markers in transfusion transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol 37:203-209, 1992
56. Laskus T, Cianciara J, Slusarczyk J: A follow-up study of an outbreak of non-A, non-B hepatitis in a plasmapheresis unit. Liver 10:49-53, 1990
57. Goncales FL Jr, Pedro R de J, da Silva LJ, Boccato RS, Goncales NS: Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates. Rev Inst Med Trop Sao Paulo 35:63-71, 1993 (in Portuguese)
58. Goncales FL Jr, Boccato RS, Pedro R de J, Papaiordanou PM, de Souza CA, Goncales NS, Pellegrino J Jr: Prevalence of HBsAG, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter. Rev Inst Med Trop Sao Paulo 35:45-51, 1993 (in Portuguese)
59. Ohto H, Nomura H, Ohmura K, Ishijima A, Okazaki S: Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C. Rinsho Byori 39:14-17, 1991 (in Japanese)
60. Kuperan P, Choon AT, Ding SH, Lee G: Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore. Southeast Asian J Trop Med Public Health 24(suppl 1):127-129, 1993
61. Richards C, Holland P, Kuramoto K, Douville C, Randell R: Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion 31:109-113, 1991
62. Wang Y-J, Lee S-D, Hwang S-J, Chan C-Y, Chow M-P, Lai S-T, Lo K-J: Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody. Vox Sang 67:187-190, 1994
63. Morris JA Jr, Wilcox TR, Reed GW, Hunter EB, Wallas CH, Steane EA, Shotts SD, Vitsky JL: Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion. Ann Surg 219:517-525, 1994
64. Norol F, Roche B, Girardin M-FSM, Kuentz M, Desforges L, Cordonnier C, Duedari N, Vernant J-P: Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 67:393-397, 1994
65. Jullien AM, Couroucé AM, Massari V, Maniez M, Finetti P, Brevière D, Girard M, Andréani T, Habibi B: Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 12:668-672, 1993
66. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN: Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 68:55-56, 1995
67. Norol F, Bachir D, Bernaudin F, Beaujean F, Desforges L, Duedari N, Galacteros F: Frozen blood and transfusion-transmitted hepatitis C virus. Vox Sang 64:150-153, 1993
68. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger BF, Gitnick G, Knodell RG, Perillo RP, Stevens CE, Hollingsworth CDG, and the National Heart. Lung and Blood Institute Study Group: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906-1911, 1992
69. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675, 1990
70. Tong MJ, el-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466, 1995
71. Strasser SI, Watson KRJ, Lee CS, Coghlan PJ, Desmond PV: Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust 162:355-358, 1995
72. Wiese M: Spontanverlauf der Virushepatitis C - Langzeitprognose einer unselektierten Gruppe mit definierter Infection. Der Kassenartz 36-38, 1996
73. Hino K, Sainokami S, Shimoda K, Niwa H, Iino S: Clinical course of acute hepatitis C and changes in HCV markers. Dig Dis Sci 39:19-27, 1994
74. Buti M, Jardi R, Rodriguez-Frias F, Quer J, Esteban R, Guardia J: Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E viruses. J Hepatol 20:589-592, 1994
75. Diepolder HM, Zachoval R, Hoffman RM, Wierenga EA, Santantonio T, Jung M-C, Eichenlaub D, Pape GR: Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007, 1995
76. Kao J-H, Tsai S-L, Chen P-J, Yang P-M, Sheu J-C, Lai M-Y, Hsu H-C, Sung J-L, Wang T-H, Chen D-S: A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: Comparison between posttransfusion and sporadic patients. J Hepatol 21:244-249, 1994
77. Gordon SC, Kodali VP, Silverman AL, Dmuchowski CF, Urdea MS, Chan CS, Wilber JC: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 89:1458-1461, 1994
78. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC: Significance of hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504, 1993
79. Neumuyr G, Judmaier G, Stoffler G, Dietze O, Vogel W: The significance of infection pathways for hepatitis C virus infection associated with chronic liver disease. Z Gastroenterol 32:338-341, 1994 (in German)
80. Pereira BJG, Wright TL, Schmid CH, Levey AS, for the New England Organ Bank Hepatitis C Study Group: A controlled study of hepatitis C transmission by organ transplantation. Lancet 345:484-487, 1945
81. Wreghitt TG, Gray JJ, Allain J-P, Poulain J, Garson JA, Deaville R, Maple C, Parameshwar J, Calne RY, Wallwork J, Alexander GJM: Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 20:768-772, 1994
82. Shuhart MC, Myerson D, Childs BH, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, Bevan CA, McDonald GB: Marrow transplantation from hepatitis C virus seropositive donors: Transmission rate and clinical course. Blood 84:3229-3235, 1994
83. Conrad EU, Gretch DR, Obermeyer KR, Moogk MS, Sayers M, Wilson JJ, Strong DM: Transmission of hepatitis C virus by tissue transplantation. J Bone Joint Surg 77A:214-224, 1995
84. Kroes ACM, de Man RA, Niesters HGM, Schalm SW, Weimar W, Balk AHMM: Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 21:1113-1115, 1994.
85. Lim HL, Lau GKK, Davis GL, Dolson DL, Lau JYN: Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 106:248-251, 1994
86. Milfred SK, Lake KD, Anderson DJ, Hayney MS, Love KR, Emery RW, Pritzker MR: Practices of cardiothoracic transplant centers regarding hepatitis C-seropositive candidates and donors. Transplantation 57:568-572, 1994
87. Cadranel JF, Grippon P, Lunel F, Desruennes M, Leger P, Azar N, Moussalli J, Pauwels A, Cabrol A, Salmon P, Charpentier YL, Cabrol C, Huraux JM, Opolon P: Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months. Transplantation 52:645-650, 1991
88. Kanamori H, Fukawa H, Maruta A, Harano H, Kodama F, Matsuzaki M, Miyashita H, Motomura S, Okuba T, Yoshiba M, Sekiyama K: Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. Am J Med Sci 303:109-111, 1992
89. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM: Withdraw of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 8:417-420, 1991
90. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O: Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm. Scand J Gastroenterol 29:360-362, 1994
91. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC: Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 153:1705-1712, 1993
92. Campello C, Majori S, Poli A, Pacini P, Nicolardi L, Pini F: Prevalence of HCV antibodies in health-care workers from northern Italy. Infection 20:224-226, 1992
93. Klein RS, Freeman K, Taylor PE, Stevens CE: Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 338:1539-1542, 1991
94. Goetz AM, Ndimbie OK, Wagener MM, Muder RR: Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 59:990-994, 1995
95. Hasebe C, van Thiel RC, Eygendaal D, Chung RT, Dienstag JL, Kaplan LM: Primary screening for viral RNA by "iterative PCR" reveals a significantly increased prevalence of hepatitis C virus (HCV) infection in health workers. Hepatology 16:72A, 1992 (abstract)
96. Zuckerman J, Clewley G, Griffiths P, Cockcroft A: Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 343:1618-1620, 1994
97. De Brouwer C, Lecomte A: HCV antibodies in clinical health-care workers. Lancet 344:962, 1994 (letter)
98. Frider B, Sookoian S, Castano G, Rebora N, Gutfraind Z, Mirta K, Veyretou F, Wainstein C: Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays. Acta Gastroenterol Latinoam 24:71-75, 1994
99. Ishiguro N, Tomimatsu M, Nagahara H, Obata H: Clinical evaluation of a newly established anti-HCV assay for the diagnosis of hepatitis C in Japan. J Gastroenterol Hepatol 7:602-607, 1992
100. Estaban JJ, Gomez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, Otero T, Moya A, Esteban R: Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334:555-560, 1995
101. Homma S, Toshima K, Shima H, Inadama E, Sato C, Kuwano T, Sato Y, Toda G: HCV viremia immediately after accidental needle stick. Int Hepatol Commun 2/3:166-169, 1994
102. Sodeyama T, Kiyosawa K, Urushihara A, Matsumoto A, Tanaka E, Furuta S, Akahane Y: Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 153:1565-1572, 1993
103. Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, Mishiro S: Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109-1114, 1992
104. Francavilla E, Rinaldi R, Cattelan AM, Vicariotto M, Botolotti F, Cadrobbi P: Low prevalence of antibodies to hepatitis C virus in hospital employees. Infection 20:295, 1992
105. Suzuki K, Mizokami M, Lau JYN, Mizoguchi N, Kato K, Mizuno Y, Sodeyama T, Kiyosawa K, Gojobori T: Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 170:1575-1578, 1994
106. Gerberding JL: Management of occupational exposures to blood-borne viruses. N Engl J Med 332:444-451, 1995
107. al-Khaja N, Roberts DG, Belboul A, Lopere V, Bergman P, Radberg G, Hermodsson S, Olssen RG: Gamma globulin prophylaxis to reduce post-transfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 25:7-12, 1991
108. Seeff LB, Zimmerman HJ, Wright EC, Finkelstein JD, Gracia-Pont P, Greenlee HB, Dietz AA, Leevy CM, Tamburro CH, Schiff ER, Schimmel EM, Zemel R, Zimmon DS, McCollum RW: A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology 72:111-121, 1977
109. Knodell RG, Conrad ME, Ishak KG: Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of γ-globulin prophylaxis and its prevention. Gastroenterology 72:902-909, 1977
110. Sanchez-Quijano A, Pineda JA, Lissen E, Leal M, Diaz-Torres MA, Garcia de Pesquera F, Rivera F, Castro R, Muũnoz J: Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1:1245-1249, 1988
111. Moaven LD, Locarnini SA, Schiff P: Passive immunisation against hepatitis C infection. Med J Aust 158:358, 1993 (letter)
112. Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM, Pendy L, Kerley LM: Hepatitis C virus infection in health care workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 15:745-750, 1994
113. Marranconi F, Mecenero V, Pellizzer GP, Bettini MC, Conforto M, Vaglia A, Stecca C, Cardone E, de Lalla F: HCV infection after accidental needlestick injury in health-care workers. Infection 20:111, 1992 (letter)
114. Laufs R, Polywka S, Feucht HH, Ebeling M, Iske L, Friedrich K, Oehler G, Keitel M, Nolte H, Thiele B: "Was bedeutet der Befund "HCV-Antikörper positiv?" Dtsch Ärzteblatt 91:A285-287, 1994
115. Inoue Y, Miyamura T, Unayama T, Takahashi K, Saito I: Maternal transfer of HCV. Nature 353:609, 1991 (letter)
116. Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, Hall JE, Hu F, Houghton M: A unique, predominant hepatitis C virus variant found in an infant horn to a mother with multiple variants. J Virol 67:4365-4368, 1993
117. Ni Y-H, Lin H-H, Chen P-J, Hsu H-Y, Chen D-S, Chang M-H: Temporal profile of hepatitis C virus antibody and genome in infants horn to mothers infected with hepatitis C virus hut without human immunodeficiency virus coinfection. J Hepatol 20:641-645, 1994
118. Lin HH, Hsu HY, Lee TY, Kao JH, Chen PJ, Chen DS: Hepatitis C virus infection in pregnant women: detection by different anti-HCV immunoassays and serum HCV-RNA. Asia Oceania J Obstet Gynaecol 20:13-18, 1994
119. Lin H-H, Kao J-H, Hsu H-Y, Ni Y-H, Yeh S-H, Hwang L-H, Chang M-H, Hwang S-C, Chen P-J, Chen D-S: Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 169:638-641, 1994
120. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S, and the Vertical Transmission of Hepatitis C Virus Collaborative Study Group: Transmission of hepatitis C virus from mothers to infants. N Engl J Med 330:744-750, 1994
121. Manzini P, Saraceo G, Cerchier A, Riva C, Musso A, Ricotti E, Palomba E, Scolfaro C, Verme G, Bonino F, Tovo PA: Human immunodeficiency virus infection at risk factor for mother-to-child hepatitis C virus transmission: persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 21:328-332, 1995
122. Roudot-Thoraval F, Pawlotsky J-M, Thiers V, Deforges L, Girollet P-P, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D: Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing. Hepatology 17:772-777, 1993
123. Lam JPH, McOmish F, Burns SM, Yap PL, Mok JYQ, Simmonds P: Infrequent vertrical transmission of hepatitis C virus. J Infect Dis 167:572-576, 1993
124. Wejstål R, Widell A, Månsson A-S, Hermodsson S, Norkrans G: Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 117:887-890, 1992
125. Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, Piazza S, Shih JW-K: Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 117:881-886, 1992
126. Wejstål R, Hermodsson S, Iwarson S, Norkrans G: Mother to infant transmission of hepatitis C virus infection. J Med Virol 30:178-180, 1990
127. Marcellin P, Bernuau J, Martinot-Peignoux M, Larzul D, Li-Zhe-Xu, Erlinger S, Benhamou JP: Risk for mother-to-infant transmission of HCV in asymptomatic anti-HCV positive women. Gastroenterology 102:A848, 1992 (abstract)
128. Kurauchi O, Fujurui T, Itakura A, Ishiko H, Sugiyama M, Ohno Y, Ando H, Tanamura A, Ishida T, Nawa A, Nomura S, Mizutani S, Tomoda Y: Studies on transmission of hepatitis C virus from mother-to-child in the perinatal period. Arch Gynecol Obstet 253:121-126, 1993
129. Uehara S, Abe Y, Saito T, Yoshida Y, Wagatsuma S, Okamura K, Yajima A, Mandai M: The incidence of vertical transmission of hepatitis C virus. Tohoku J Exp Med 171:195-202, 1993
130. Thaler MM, Park C-K, Landers DV, Wara DW, Houghton M, Veereman-Wauters G, Sweet RL, Han JH: Vertical transmission of hepatitis C virus. Lancet 338:17-18, 1991
131. Novati R, Thiers V, Monforte AD, Maisonneuve P, Principi N, Conti M, Lazzarin A, Brechot C: Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 165:720-723, 1992
132. Giovannini M, Tagger A, Rihero ML, Zuccotti G, Pogliani L, Grossi A, Ferroni P, Fiocchi A: Maternal-infant transmission of hepatitis C virus and HIV infections: A possible interaction. Lancet 335:1166, 1990 (letter)
133. Weintrub PS, Veereman-Wauters GL, Cowan MJ, Thaler MM: Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J Pediatr 119:869-874, 1991
134. Lin H-H, Kao J-H, Hsu H-Y, Ni Y-H, Chang M-H, Huang S-C, Hwang L-H, Chen P-J, Chen D-S: Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 126:589-591, 1995
135. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 339:1007-1012, 1992
136. Peckham C, Gibb D: Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 333:298-302, 1995
137. European Collaborative Study: Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343:1464-1467, 1994
138. Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, Bryson YJ: Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 271:1925-1930, 1994
139. Umlauft F, König P, Weyrer K, Grünewald K, Vogel W: Hepatitis C virus infection in patients on maintenance hemodialysis. Hepatology 16:224A, 1992 (abstract)
140. Sakamoto N, Enomoto N, Marumo F, Sato C: Prevalence of hepatitis C virus infection among long-term hemodialysis patients: Detection of hepatitis C virus RNA in plasma. J Med Virol 39:11-15, 1993
141. Hussein MM, Mooij JMV, Roujoulch H, El Sayed H: Observ vations in a Saudi-Arabian dialysis population over a 13-year period. Nephrol Dial Transplant 9:1072-1076, 1994
142. Dussol B, Berthezène P, Brunei P, Roubicek C, Berland Y: Hepatitis C virus infection among chronic dialysis patients in the South of France: A collaborative study. Am J Kidney Dis 25:399-404, 1995
143. Ng Y-Y, Lee S-D, Wu S-C, Yang W-C, Chiang S-S, Huang T-P: Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 35:263-266, 1991
144. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Crepaldi M, Pagano A, Locatelli F: Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant 9:1611-1615, 1994
145. Dienstag JL, Stevens CE, Szmuness W: The epidemiology of non-A, non-B hepatitis: emerging patterns. In Non-A, Non-B Hepatitis, RJ Gerety (ed). New York, Academic Press, 1981, pp 119-138
146. Lok ASF, Chan TM, Chan R, Cheng IKP: HCV infection in hemodialysis (HD) patients: A comparative study using 1st and 2nd generation EIA for anti-HCV and PCR for HCV-RNA. Gastroenterology 102:A845, 1992 (abstract)
147. Cahn TM, Lok ASF, Cheng IKP, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5-8, 1993
148. Jadoul M, Cornu C, van Ypersele de Strihou C, and the UCL Collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44:1322-1326, 1993
149. Pol S, Romeo R, Zins B, Lebkiri B, Berthelot P, Bréchot C: High frequency of HCV viremia in antiHCV positive hemodialyzed patients. Hepatology 16:218A, 1492 (abstract)
150. Gerritzen A, Klehr U, Scholt B, Kaiser R, Lutzke G, Ferber J, Schneweis KE: Infektionsrisiko durch Hepatitis C virus bei der Hämodialyse. Klin Woschenr 69(suppl 28):36, 1992 (abstract)
151. Alter MJ: Epidemiology of hepatitis C in the West. Semin Liver Dis 15:5-14, 1995
152. Neal KR, Jones DA, Killey D, James V: Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect 112:595-601, 1994
153. Marranconi F, Fabris P, Stecca C, Zampieri L, Bettini MC, De Fabrizio N, de Lalla F: Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 22:333-337, 1994
154. Allander T, Gruber A, Naghavi M, Beyene A, Soderstrom T, Bjorkholm M, Grillner L, Persson MA: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345:603-607, 1995
155. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D: Risque de transmission du virus de l'hepatite C par l'endoscopie digestive. Gastroenterol Clin Biol 19:346-349, 1995
156. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K, Furuta S, Watanabe Y, Watanabe J, Fukuda Y, Takayama T, and the South Kiso Hepatitis Study Group: Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. Gastroenterology 106:1596-1602, 1994
157. Mele A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA, Ferrigno L, Rapicetta M, Franco E, Adamo B, Palumbo F, Sbreglia C, Paná A, Pasquini P, and the SEIEVA Collaborating Group: Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: A case-control study. Am J Public Health 84:1640-1643, 1994
158. Piazza M, Borgia G, Picciotto L, Nappa S, Cicciarello S, Orlando R: Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. J Med Virol 45:40-42, 1995
159. Abe K, Inchauspe G: Transmission of hepatitis C by saliva. Lancet 337:248, 1991 (letter)
160. Abe K, Kurata T, Shikata T, Sugitani M, Oda T: Experimental transmission of non-A, non-B hepatitis by saliva. J Infect Dis 155:1078-1079, 1987
161. Wang J-T, Wang T-H, Lin J-T, Sheu J-C, Lin S-M, Chen D-S: Hepatitis C virus RNA in saliva of patients with post-transfusion hepatitis C infection. Lancet 337:48, 1991 (letter)
162. Takamatsu K, Koyanagi Y, Okita K, Yamamoto N: Hepatitis C virus in saliva. Lancet 336:1515, 1990 (letter)
163. Couzigou P, Richard L, Dumas F, Schouler L, Fleury H: Detection of virus C RNA in saliva of patients with chronic hepatitis C. Gastroenterology 102:A795, 1992 (abstract)
164. Dusheiko GM, Smith M, Scheuer PJ: Hepatitis C virus transmitted by human bite. Lancet 336:503-504, 1990 (letter)
165. Riestra Menédez S, Rodríiguez Garcia M, Sánchez San Román F, Menéndez Tévar F, Suárez Gonzalez A, Alvarez Navascués C, Pérez Alvarez R, Rodrigo Aáez L: Intrafamilial spread of hepatitis C. Infection 19:431-433, 1991
166. Tumminelli F, Marcellin P, Rizzo S, Barbera S, Corvino G, Furia P, Benhamou JP, Erlinger S: Shaving as potential source of hepatitis C virus infection. Lancet 345:658, 1995 (letter)
167. Gordon SC, Patel AH, Kulesza GW, Barnes RE, Silverman AL: Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 87:1849-1851, 1992
168. Napoli N, Fiore G, Vella F, Fera G, Schiraldi O: Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C. Eur J Epidemiol 9:629-632, 1993
169. Chang T-T, Liou T-C, Young K-C, Lin X-Z, Lin C-Y, Shin J-S, Wu H-L: Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 42:91-96, 1994
170. Kiyosawa K, Sodeyama T, Tanaka E, Shimizu S, Furuta S, Miyazaki Y, Akhane Y, Suzuki H: Intrafamilial transmission of hepatitis C virus in Japan. J Med Virol 33:114-116, 1991
171. Mondello P, Patti S, Vitale MG, D'Accardo AM, Spanó C: Anti-HCV antibodies in household contacts of patients with cirrhosis of the liver - preliminary results. Infection 20:51-52, 1992 (letter)
172. Kaplan AJ, Zone-Smith LK, Hannegan C, Norcross ED: The prevalence of hepatitis C in a regional level I trauma center population. J Trauma 33:126-128, 1992
173. Crofts N, Steward T, Hearne P, Ping XY, Breschkin AM, Locarnini SA: Spread of bloodborne viruses among Australian prison entrants. Br Med J 31:285-288, 1995
174. Thomas DL, Mahley RW, Badur S, Palaoglu E, Quinn TC: The epidemiology of hepatitis C in Turkey. Infection 22:411-414, 1994
175. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ, for the Multicenter Hemophilia Cohort Study: Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 84:1020-1023, 1994
176. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Piette JC, Huraux J-M, Opolon P: Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300, 1994
177. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993
178. Doutrelepont J-M, Adler M, Willems M, Durez P, Yap S-H: Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet 341:317, 1993 (letter)
179. Harlé J-R, Disdier P, Dussol B, Bolla G, Casanova P, Weiller P-J: Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet 341:904, 1993 (letter)
180. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
181. Ferri C, Zignego AL, Longombardo G, Monti M, La Civita L, Lombardini F, Greco F, Mazzoni A, Pasero G, Gentilini P, Bombardieri S, Manns M: Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients. Infection 21:93-97, 1993
182. Bonomo L, Casato M, Afeltra A, Caccavo D: Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 83:726-730, 1987
183. Bibas M, Andriani A: Hepatitis C virus and cryglobulinaemia. N Engl J Med 328:1123, 1993 (letter)
184. Marcellin P, Descamps V, Martinot-Peignoux M, Larzul D, Xu L, Booyer M, Pham BN, Crickx B, Guillevin L, Belaich S, Erlinger S, Benhamou JP: Cryoglobulinaemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104:272-277, 1993
185. D'Amico G, Fornasieri A: Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 25:361-369, 1995
186. Hartwell P, Willson R, Hart J, Johnson R: Chronic hepatitis C, glomerulonephritis, and alpha interferon-2b. Gastroenterology 102:A818, 1992 (abstract)
187. Johnson RJ, Gretch DR, Conser WG, Alpers CE, Wilson J, Chung M, Hart J, Willson R: Hepatitis C virus-associated glomerulonephritis. Effect of α-interferon therapy. Kidney Int 46:1700-1704, 1994
188. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Régnier D, Beusnel C, Sadoul JL, Hébuterne X, Rampel P: High prevalence of Hashimoto's thyroiditis in female patients with chronic hepatitis C prior to treatment by interferon. Gastroenterology 104(suppl):A1011, 1993 (abstract)
189. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul J-L, Hébuterne X, Rampel P: High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:1253-1257, 1993
190. Marcellin P, Pouteau M, Renard P, Grynblat J-M, Linhardt NC, Bardet P, Bok B, Benhamou J-P: Sustained hvpothyroidism induced by recombinant a interferon in patients with chronic hepatitis C. Gut 33:855-856, 1993
191. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 102:2155-2160, 1992
192. Pawlotsky JM, BenYahia M, André C, Voisin MC, Intrator L, Deforges L, Duvoux C, Zafrani ES, Duval J, Dhumeaux D: Immunological disorders associated with C viral chronic hepatitis: A prospective evaluation. Hepatology 16:217A, 1992 (abstract)
193. Haddad J, Deny P, Munz-Gotheil C, Ambrosini J-C, Trinchet J-C, Pateron D, Mal F, Callard P, Beaugrand M: Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323, 1992
194. King PD, McMurray RW, Becherer PR: Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 89:1047-1050, 1994
195. Pawlotsky JM, Benchiki H, Pellet C, Duval J, Dhumeaux D, Revuz J, Bagot M: Lichen planus and hepatitis C virus (HCV)-related chronic hepatitis: evaluation of HCV genotypes. Br J Dermatol 133:666-667, 1995 (letter)
196. Allison MED, Wreghitt T, Plamer CR, Alexander GJ: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21:1135-1139, 1994
197. Cacoub P, Lunel-Fabiani F, Houng Du LT: Polyarteriitis nodosa and hepatitis C virus infection. Ann Intern Med 116:605-606, 1992
198. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME: Frequency and significance of antibodies to hepatitis C virus in polyarteriitis nodosa. J Rheumatol 20:304-309, 1993
199. Fargion S, Piperno A, Capellini MD, Sampietro M, Fracanzani AL, Romano R, Calderelli R, Marcelli R, Vecchi L, Fiorelli G: Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16:1322-1326, 1992
200. DeCastro M, Sánchez J, Herrera JF, Cháves A, Durán R, García-Buey L, García-Monzón C, Sequí J, Moreno-Otero R: Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 17:551-557, 1993
201. Ferri C, Baicchi U, La Civita L, Greco F, Longombardo G, Mazzoni A, Careccia G, Bombardieri S, Pasero G, Zignego AL, Manns MP: Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 23:851-855, 1993
202. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, Terés J, Mascaró JM, Rodés J: Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 341:788-789, 1993
203. Stölzel U, Köstler E, Koszka C, Stöffler-Meilicke M, Schuppan D, Somasundaram R, Doss MO, Habermehl KO, Riceken EO: Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21:1500-1503, 1995
204. Murphy A, Dooley S, Hillary IB, Murphy GM: HCV infection in porphyria cutanea tarda. Lancet 341:1534-1535, (letter)
205. Perrillo RP, Pohl DA, Roodman ST, Tsai CC: Acute non-A, non-B hepatitis with serum sickness-like syndrome and aplastic anemia. JAMA 245:495-496, 1981
206. Zeldis JB, Dienstag JL, Gale RP: Aplastic anemia and non-A, non-B hepatitis. Am J Med 74:64-68, 1983
207. Pol S, Driss F, Devergie A, Brechot C, Berthelot P, Gluckman B: Is hepatitis C virus involved in hepatitis-associated aplastic anemia? Ann Intern Med 113:435-437, 1990
208. Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, Tzakis AG, Alter HJ, Young NS: Aplastic anemia and viral hepatitis. Non-A, non-B, non-C? JAMA 267:2051-2054, 1992
209. Pol S, Thiers V, Driss F, Devergie A, Berthclot P, Brechot C, Gluckman E: Lack of evidence for a role of HCV in hepatitis-associated aplastic anemia. Br J Haematol 85:808-810, 1993
210. Strassburg CP, Manns MP: Autoimmune hepatitis versus viral hepatitis C. Liver 15:225-232, 1995
211. Ruis-Moreno M, Rúa MJ, Carreño V, Quiroga JA, Manns M, Meyer zum Büschenfelde K-H: Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children. J Hepatol 12:265-266, 1991 (letter)
212. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou J-P: Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 116:51-53, 1992
213. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613-619, 1995
214. Manns M, Scheucher S, Jentsch M, Broly F, Goergen B, Schneider P, Gerken G, Rittner Ch, Meyer zum Büschenfeld K-H, Meyer UA: Genetics in autoimmune hepatitis type 2. Hepatology 14:60A, 1991 (abstract)
215. Lenzi M, Mantovani W, Cataleta M, Ballardini G, Cassani F, Giostra F, Muratori L, Bianchi FB: HLA-typing in autoimmune hepatitis (AI-CAH) type 2. J Hepatol 16(suppl 1:S59, 1992
216. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108:157-164, 1995
217. Verdon R, Pol S, Landais P, Mattlinger B, Carnot F, Brechot C, Busson M, Kreis H: Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialized patients. J Hepatol 21:388-343, 1494
218. Vitte RL, Fortier C, Richardet JP, Grimbert S, Trinchet JC, Beaugran M, Lepage V, Raffoux C: HLA antigens in patients with chronic hepatitis C. Tissue Antigens 45:356-361, 1995
219. Peano G, Menardi G, Ponzetto A, Fenoglio LM: HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 154:2733-2736, 1994
220. Silverman AL, Puccio JE, Kulesza GW, McCray DG, Gordon SC: HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am J Gastroenterol 89:1201-1202, 1994
221. Choo Q-L, Kuo G, Ralson R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopou J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E: Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 91:1294-1298, 1994